Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints
Lupus nephritis (LN) is a common manifestation of systemic lupus erythematosus (SLE) and a major driver of morbidity and mortality. Proliferative forms of LN are typically managed with immunosuppressive therapy, with the aim of attenuating renal inflammation and preserving kidney function.1Almaani S...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | engelsk |
| Udgivet: |
2020
|
| Online adgang: | https://doi.org/10.1016/j.ekir.2020.05.011 http://www.kireports.org/article/S2468024920312729/pdf |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|